Evaluation, in three provinces, of the introduction and impact of China’s National Essential Medicines Scheme
Authors:
- 11 January 2013
- journal article
- research article
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 91 (3) , 184-194
Abstract
To evaluate implementation of the National Essential Medicines Scheme (NEMS) in rural China. Two rural counties/districts in each of three provinces where NEMS had been implemented were surveyed. Information was collected from NEMS staff at the province, county/district, township and village levels; patients with chronic disease were also interviewed. Service provision, finances, prescriptions, inpatient records and the expenditures of patients with certain diagnoses were investigated in township hospitals and village clinics. The results were compared with the corresponding data recorded before NEMS was introduced. Following the introduction of NEMS, drug procurement in each study location was systematized. Total drug costs declined. This, and improved prescribing, reduced the costs of outpatient and inpatient care and led, apparently, to increased uptake of health services. However, the prices of some drugs had increased and the availability of others had declined. The compensation of health-care providers for NEMS-related reductions in their incomes had been largely ineffective. As a result of the introduction of NEMS, health facilities relied more on public financing. Many health-care providers complained about higher workloads and lower incomes. Although it was well conceived, the introduction of NEMS into China's decentralized, fee-for-service system of health care has not been straightforward. It has highlighted the problems associated with attempts to modernize health care and health financing for patients' benefit. Sustainable mechanisms to compensate health-care providers for lost income are needed to ensure that NEMS is a success.Keywords
This publication has 21 references indexed in Scilit:
- Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional studyThe Lancet, 2012
- Pharmaceutical supply chain in China: Current issues and implications for health system reformHealth Policy, 2010
- Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provincesBMC Health Services Research, 2010
- Prescribing behaviour of village doctors under China's New Cooperative Medical SchemeSocial Science & Medicine, 2009
- Reform of how health care is paid for in China: challenges and opportunitiesThe Lancet, 2008
- Tackling the challenges to health equity in ChinaThe Lancet, 2008
- Antibiotic prescribing patterns in village health clinics across 10 provinces of Western ChinaJournal of Antimicrobial Chemotherapy, 2008
- Privatization and Its Discontents — The Evolving Chinese Health Care SystemNew England Journal of Medicine, 2005
- Prescribing practices of rural primary health care physicians in UzbekistanTropical Medicine & International Health, 2003
- Drug Prescribing in Rural Health Facilities in China: Implications for Service Quality and CostTropical Doctor, 1998